Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Number of items ‘dispensed in the community’ spikes 13% in a decade

The latest NHS data has revealed that the number of items dispensed in the community rose 3% last year, while the cost of prescriptions rose for the fifth year in a row. 

Some 1.21 billion prescription items were dispensed in England in the community in 2023/24, the NHS Business Services Authority (NHS BSA) revealed today (June 6).

It said that this was a 3% increase from the 1.18bn items that were “dispensed in the community” – meaning by pharmacies, appliance contractors and dispensing doctors or “personally administered” - in 2022/23.

“Compared to 2014/15, the number of items dispensed has increased by 13%,” it added.

It also revealed that the prescriptions dispensed in the community in 2023/24 set the NHS back by £10.9bn.

This was “a 5% increase from £10.4bn in 2022/23” and the fifth year in a row that costs have risen since in a dip in 2018/19, it added.

 

Atorvastatin most dispensed

 

The NHS BSA’s analysis also found that for the fourth year running, the “most dispensed chemical substance was Atorvastatin, with 65 million items”.

Meanwhile, steroid beclometasone dipropionate had the highest cost of £320m, it said.

“The top ten chemical substances by cost included three drugs that are commonly used to help prevent blood clots” – “these are Apixaban, Rivaroxaban and Edoxaban,” it added.

And 10mg tablets of diabetes drug Forxiga saw the largest increase in cost from last year “with an absolute increase of £90m”, it said.

The analysis included medicines supplied as part of the Pharmacy First service, the NHS BSA added. 

Meanwhile, a C+D poll revealed last August that atorvastatin shortages caused almost half of respondents to face losses of more than £1,000.

At the time, a wholesalers' representative told C+D that changes to prescribing guidelines and an “IT issue” at a major manufacturer were to blame for price hikes and shortages.

Related Content

Topics

         
Pharmacy Manager
Newquay, Cornwall
£ Competitive

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD138246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel